2022 Q4 Form 10-Q Financial Statement

#000114036122041459 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $614.1K $413.3K $473.0K
YoY Change -50.42% -12.61% -56.29%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $401.5K $465.9K $551.0K
YoY Change -47.57% -15.44% -45.65%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.720K $2.740K $2.800K
YoY Change -2.16% -2.14% -1.06%
% of Gross Profit
Operating Expenses $666.5K $602.3K $820.2K
YoY Change -43.44% -26.57% -41.71%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$52.39K -$189.0K -$347.3K
YoY Change -187.0% -45.58% 6.79%
Income Tax $9.370K $0.00 $0.00
% Of Pretax Income
Net Earnings -$61.76K -$189.0K -$347.3K
YoY Change -203.8% -45.58% 31.45%
Net Earnings / Revenue -10.06% -45.73% -73.42%
Basic Earnings Per Share -$0.31 -$0.58
Diluted Earnings Per Share -$0.10 -$0.31 -$578.7K
COMMON SHARES
Basic Shares Outstanding 600.1K 600.1K 600.1K
Diluted Shares Outstanding 600.1K 600.1K

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.286M $2.385M $2.927M
YoY Change -20.89% -18.5% -45.9%
Cash & Equivalents $2.286M $2.385M $2.927M
Short-Term Investments
Other Short-Term Assets $350.0K $350.0K $350.0K
YoY Change 0.0% 0.0% 75.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $3.277M $3.295M $3.760M
YoY Change -9.51% -12.35% -34.71%
LONG-TERM ASSETS
Property, Plant & Equipment $11.77K $14.50K $25.48K
YoY Change -48.15% -43.1% -28.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $128.8K $174.2K $205.7K
YoY Change -81.04% -15.32% 27.9%
Total Long-Term Assets $140.6K $188.7K $231.2K
YoY Change -79.98% -18.38% -61.18%
TOTAL ASSETS
Total Short-Term Assets $3.277M $3.295M $3.760M
Total Long-Term Assets $140.6K $188.7K $231.2K
Total Assets $3.418M $3.484M $3.991M
YoY Change -20.96% -12.7% -37.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.268M $1.288M $707.9K
YoY Change 65.8% 81.95% 17.89%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.331M $1.335M $754.8K
YoY Change 63.69% 76.9% 6.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $259.4K
YoY Change -44.57%
Total Long-Term Liabilities $0.00 $0.00 $259.4K
YoY Change -100.0% -100.0% -44.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.331M $1.335M $754.8K
Total Long-Term Liabilities $0.00 $0.00 $259.4K
Total Liabilities $1.331M $1.335M $1.014M
YoY Change 3.34% 31.65% -13.61%
SHAREHOLDERS EQUITY
Retained Earnings -$51.81M -$51.74M
YoY Change 1.87%
Common Stock $6.001K $6.001K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.087M $2.149M $2.977M
YoY Change
Total Liabilities & Shareholders Equity $3.418M $3.484M $3.991M
YoY Change -20.96% -12.7% -37.19%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$61.76K -$189.0K -$347.3K
YoY Change -203.8% -45.58% 31.45%
Depreciation, Depletion And Amortization $2.720K $2.740K $2.800K
YoY Change -2.16% -2.14% -1.06%
Cash From Operating Activities -$99.81K -$115.0K -$210.1K
YoY Change 163.42% -45.24% -147.04%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -99.81K -115.0K -210.1K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -99.81K -115.0K -210.1K
YoY Change 163.42% -45.24% -147.04%
FREE CASH FLOW
Cash From Operating Activities -$99.81K -$115.0K -$210.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
0
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-73996
dei Entity Registrant Name
EntityRegistrantName
Morgan Group Holding Co
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-4196940
dei Entity Address City Or Town
EntityAddressCityOrTown
Rye
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10580
dei City Area Code
CityAreaCode
914
dei Local Phone Number
LocalPhoneNumber
921-5216
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
MGHL
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
600090
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
600090
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
600090
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001162283
dei Security Exchange Name
SecurityExchangeName
NONE
dei Document Type
DocumentType
10-Q
dei Entity Address Address Line1
EntityAddressAddressLine1
401 Theodore Fremd Avenue
dei Entity Small Business
EntitySmallBusiness
true
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
0
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
0
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
6311
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-251180
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-196059
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.01
mghl Number Of Nyse Member Firms Through Which All Securities Transactions Are Cleared
NumberOfNYSEMemberFirmsThroughWhichAllSecuritiesTransactionsAreCleared
3
mghl Underwriter Payment Receiving Maximum Period
UnderwriterPaymentReceivingMaximumPeriod
P90D
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
389823
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
492191
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1343225
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1720546
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
-0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
10667
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-188991
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-347270
us-gaap Net Income Loss
NetIncomeLoss
-887436
us-gaap Net Income Loss
NetIncomeLoss
-1630560
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.72

Files In Submission

Name View Source Status
0001140361-22-041459-index-headers.html Edgar Link pending
0001140361-22-041459-index.html Edgar Link pending
0001140361-22-041459.txt Edgar Link pending
0001140361-22-041459-xbrl.zip Edgar Link pending
brhc10044009_10q.htm Edgar Link pending
brhc10044009_ex31-1.htm Edgar Link pending
brhc10044009_ex31-2.htm Edgar Link pending
brhc10044009_ex32-1.htm Edgar Link pending
brhc10044009_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mghl-20220930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mghl-20220930_cal.xml Edgar Link unprocessable
mghl-20220930_def.xml Edgar Link unprocessable
mghl-20220930_pre.xml Edgar Link unprocessable
mghl-20220930_lab.xml Edgar Link unprocessable
brhc10044009_10q_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending